Opin vísindi

GWAS meta-analysis reveals key risk loci in essential tremor pathogenesis

GWAS meta-analysis reveals key risk loci in essential tremor pathogenesis


Titill: GWAS meta-analysis reveals key risk loci in essential tremor pathogenesis
Höfundur: Estonian Biobank
DBDS Genomic Consortium
Útgáfa: 2024-04-26
Tungumál: Enska
Umfang: 1
Háskóli/Stofnun: Landspitali - The National University Hospital of Iceland
Deild: Faculty of Medicine
Faculty of Industrial Engineering, Mechanical Engineering and Computer Science
Other departments
Faculty of Icelandic and Comparative Cultural Studies
Birtist í: Communications Biology; 7(1)
ISSN: 2399-3642
DOI: 10.1038/s42003-024-06207-4
Efnisorð: Öldrunarlæknisfræði; Taugasjúkdómafræði; Medicine (miscellaneous); General Biochemistry,Genetics and Molecular Biology; General Agricultural and Biological Sciences
URI: https://hdl.handle.net/20.500.11815/4911

Skoða fulla færslu

Tilvitnun:

Estonian Biobank & DBDS Genomic Consortium 2024 , ' GWAS meta-analysis reveals key risk loci in essential tremor pathogenesis ' , Communications Biology , vol. 7 , no. 1 , pp. 504 . https://doi.org/10.1038/s42003-024-06207-4

Útdráttur:

Essential tremor (ET) is a prevalent neurological disorder with a largely unknown underlying biology. In this genome-wide association study meta-analysis, comprising 16,480 ET cases and 1,936,173 controls from seven datasets, we identify 12 sequence variants at 11 loci. Evaluating mRNA expression, splicing, plasma protein levels, and coding effects, we highlight seven putative causal genes at these loci, including CA3 and CPLX1. CA3 encodes Carbonic Anhydrase III and carbonic anhydrase inhibitors have been shown to decrease tremors. CPLX1, encoding Complexin-1, regulates neurotransmitter release. Through gene-set enrichment analysis, we identify a significant association with specific cell types, including dopaminergic and GABAergic neurons, as well as biological processes like Rho GTPase signaling. Genetic correlation analyses reveals a positive association between ET and Parkinson's disease, depression, and anxiety-related phenotypes. This research uncovers risk loci, enhancing our knowledge of the complex genetics of this common but poorly understood disorder, and highlights CA3 and CPLX1 as potential therapeutic targets.

Athugasemdir:

Publisher Copyright: © 2024. The Author(s).

Skrár

Þetta verk birtist í eftirfarandi safni/söfnum: